Results 21 to 30 of about 116,030 (357)

Transcatheter Aortic Valve Therapy for Bicuspid Aortic Valve Stenosis

Journal of Cardiovascular Development and Disease, 2023
Transcatheter aortic valve implantation (TAVI) has become first-line treatment for older adults with severe aortic stenosis (AS), however, patients with bicuspid aortic valve (BAV) have been traditionally excluded from randomised trials and guidelines.
Nalin H. Dayawansa, Samer Noaman, Lung En Teng, Nay Min Htun   +3 more
openaire   +3 more sources

Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. [PDF]

PLoS ONE, 2013
There are no rigorously confirmed effective medical therapies for calcific aortic stenosis. Hypercholesterolemic Ldlr (-/-) Apob (100/100) mice develop calcific aortic stenosis and valvular cardiomyopathy in old age.
Robert M Weiss, Donald D Lund, Yi Chu, Robert M Brooks, Kathy A Zimmerman, Ramzi El Accaoui, Melissa K Davis, Georges P Hajj, M Bridget Zimmerman, Donald D Heistad   +9 more
doaj   +1 more source

IL6 gene polymorphism association with calcific aortic valve stenosis and influence on serum levels of interleukin-6

Frontiers in Cardiovascular Medicine, 2022
Aortic valve stenosis is the most frequent valve disease in developed countries and its prevalence will increase with population aging. There is still no pharmaceutical treatment nor biomarker to determine the susceptibility to develop aortic stenosis ...
Alejandro Junco-Vicente, Guillermo Solache-Berrocal, Álvaro del Río-García, Valeria Rolle-Sóñora, Sheila Areces, César Morís, César Morís, César Morís, María Martín, María Martín, Isabel Rodríguez   +10 more
doaj   +1 more source

Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease [PDF]

, 2012
Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Beiras Fernández, Andrés, Bigdeli, Amir K., Kaczmarek, Ingo, Michel, Sebastian, Schmitz, Christoph, Sodian, Ralf, Wolf, Manuel   +6 more
core   +2 more sources

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis

Circulation, 2021
After 15 years of successive randomized, controlled trials, indications for transcatheter aortic valve replacement (TAVR) are rapidly expanding. In the coming years, this procedure could become the first line treatment for patients with a symptomatic severe aortic stenosis and a tricuspid aortic valve anatomy.
Vincent, Flavien, Ternacle, Julien, Denimal, Tom, Shen, Mylène, Redfors, Bjorn, Delhaye, Cédric, Simonato, Matheus, Debry, Nicolas, Verdier, Basile, Shahim, Bahira, Pamart, Thibault, Spillemaeker, Hugues, Schurtz, Guillaume, Pontana, François, Thourani, Vinod, Pibarot, Philippe, van Belle, Eric   +16 more
openaire   +3 more sources

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Baglin A, Braun J, Bryg RJ, Christian Kupatt, Cribier A, Edwards FH, Gerhard Steinbeck, Herzog CA, Iung B, Leon MB, London GM, Lucke JC, Maher ER, Matthias Wessely, Michael Fischereder, Philipp Lange, Rodes-Cabau J, Simon Rau, Smith CR, Stinebaugh J, Straumann E, Tanaka K, Ulf Schönermarck, Urena P, Varadarajan P, Varma R   +25 more
core   +1 more source

High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis [PDF]

, 2014
Aims: High-sensitivity cardiac troponin I (cTnI) assays hold promise in detecting the transition from hypertrophy to heart failure in aortic stenosis.
A. L. Hunter, A. Maria Choy, A. S. V. Shah, C. C. Lang, C. W. L. Chin, Cowell, D. A. McAllister, D. E. Newby, Dweck, Dweck, F. E. Strachan, J. P. Langrish, M. R. Dweck, Messroghli, Mills, N. A. Boon, N. L. Mills, Nkomo, Rosjo, S. Alam, S. Joanna Cowell, S. Walker, Thygesen, Wieczorek   +23 more
core   +5 more sources

Possible predicative role of electrical risk score on transcatheter aortic valve replacement outcomes in older patients. preliminary data [PDF]

, 2018
Background:Transcatheter aortic valve replacement (TAVR) is an effective procedure capable to change the natural history of the degenerative aortic valve stenosis.
DI IORIO, Claudia, Fabietti, Marcella, Magri', Damiano, Mancone, Massimo, Mariani, MARCO VALERIO, Mastropietri, Fabiola, Moscucci, Federica, Parrotta, Ilaria, Piccirillo, Gianfranco, Sardella, Gennaro   +9 more
core   +1 more source

Aortic valve stenosis: Prognosis and therapy

Vojnosanitetski pregled, 2003
There is a long latent period in the clinical course of aortic valve stenosis in adults. Symptoms usually occur in the case of critical stenosis, when aortic orifice area is under 0.7cm2 (0.4 cm2/m2). In this study 78 patients with critical aortic valve stenosis were investigated. The first manifestation of the disease was dyspnea (78.2%), angina (52.5%
Milorad Damnjanović, Radomir Matunovic, Slobodan Obradovic, Jovanka Milovanović, Branko Gligic, Andelka Ristić-Andelkov   +5 more
openaire   +4 more sources

Prosthetic Aortic Valve Stenosis in End-Stage Renal Failure

International Journal of Nephrology, 2011
Although renal failure is one of the known comorbidities associated with rapid progression of aortic stenosis, it is unclear whether hemodialysis alters the progression of prosthetic aortic valve stenosis.
Michael Mao, Mirelle El Ters, Sunil Mankad, Mira Keddis, Soon Park, Qi Qian   +5 more
doaj   +1 more source